secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2021-08-06T23:59:59+00:00
Accession:  0001193125-21-238355
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mednax Q2: GAAP EPS $0.36, adj EPS $0.41, revenue $473M (+14% YoY), volume strong
--------------------------------------------------------------------------------

- Net revenue $473M vs $415.4M prior year; income from cont ops $30.5M ($0.36 diluted) vs $7.1M ($0.08).
- Adjusted EPS $0.41 vs $0.26; adjusted EBITDA $65.5M vs $55.7M.
- Same-unit revenue +13.4% (volume +9.5%, reimbursement +3.9%); office-based services volume +23.2%.
- No CARES Act funds in Q2'21 vs $5.8M in Q2'20; gain on building sale $7.3M excluded from adj metrics.
- Redeemed $750M 5.25% notes due 2023 in Jan 2021; debt now $1.0B with no revolver borrowings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312521238355/0001193125-21-238355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312521238355/d212310d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-238355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer